Wednesday, January 9, 2013

H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData

January 8, 2013
US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic spike, predicts business intelligence provider GlobalData in its latest epidemiology report, which finds that seasonal influenza vaccine demand will increase from the 142 million expected for 2012 to 158 million in 2022, representing an annual growth rate (AGR) of 1.2%.


No comments: